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Abstract 
The indole-diterpene paxilline is a potent mammalian tremorgenic mycotoxin and a 
known inhibitor of maxi-K ion channels. The gene cluster encoding the enzymes 
for the synthesis of this compound was recently c loned from Penicillium paxi/li 
(Young et al. 200 1). The cluster comprises a set of core genes required for indole-
diterpene biosynthesis , including two cytochrome P450 monooxygenases, paxP 
and paxQ. Targeted deletion of paxP and paxQ resulted in mutant strains that 
accumulate paspaline and 13-desoxypaxilline, respectively, confirmi ng that both 
genes are involved in paxilline biosynthesis. The aim of the current work is to 
establish in virro that PaxP and PaxQ catalyse the monooxygenation of paspaline 
and 13-desoxypaxilline, respectively. To achieve thi s, cDNA copies of both genes 
were cloned into pGEX-6P-3, to generate pRL2 and pRL4, and the co1Tesponding 
glutathione-S-transferase (GST) fusion proteins over-expressed in E. coli. 
However, both GST-fusion proteins accumulated as insoluble inclusion bodies 
when cultures were incubated at 18°C, 25°C and 37°C. Attempts to express a 
soluble form of the GST-PaxP by co-expressing this fus ion with the chaperones, 
GroES and GroEL, or by expressing in E. coli, Origami B, a strai n (lrxB, gor, lacY) 
designed to facilitate expression of active and soluble proteins, were unsuccessful. 
GST-PaxP was ab le to be solubilised by the addition of 0.25 % 
N-laurylsarcosine, and retained some glutathione binding act ivity, however, the 
yield was too low to carry out further experiments. GST and thioredoxin fusion 
expression construc ts were designed in which the putative N-terminal trans-
membrane region of PaxP and PaxQ was removed to aid sol ubility in E. coli. 
These N-terminal modified fusion proteins were sti ll expressed as insoluble 
protein. 
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